Skip to main content
Premium Trial:

Request an Annual Quote

New Products: GeneDx's SCID Panel

Premium

GeneDx has launched its Comprehensive Severe Combined Immunodeficiency, or SCID, panel, which uses next-gen sequencing to screen 18 genes associated with SCID disorders.

Additionally, two sub-panels that target a subset of the 18 genes are available, including the B+ SCID sub-panel that targets 10 genes associated with SCID disorders that display a B+ lymphocyte profile, and the B- SCID sub-panel that targets eight genes associated with the B- lymphocyte profile.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.